Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo M Croce

Showing results (541-550 of 549) with videos related to

Pageof 55
Sort By:
You have reached the last page of results.This site can display upto 549 results.
Cell Death and Differentiation|October 17, 2018
Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicineMichele Carbone, Ivano Amelio, El Bachir Affar, et al.
The New England Journal of Medicine|April 22, 2005
Familial cancer associated with a polymorphism in ARLTS1George Adrian Calin, Francesco Trapasso, Masayoshi Shimizu, et al.
Gastroenterology|November 9, 2017
MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in CholangiocarcinomaAndrea Lampis, Pietro Carotenuto, Georgios Vlachogiannis, et al.
Cancer Cell|April 17, 2014
MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancerNicola Valeri, Chiara Braconi, Pierluigi Gasparini, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2008
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancerLin Zhang, Stefano Volinia, Tomas Bonome, et al.
Journal of the National Cancer Institute|October 13, 2014
Pluripotent stem cell miRNAs and metastasis in invasive breast cancerStefano Volinia, Gerard Nuovo, Alessandra Drusco, et al.
American Journal of Human Genetics|August 5, 2008
WW-domain-containing oxidoreductase is associated with low plasma HDL-C levelsJenny C Lee, Daphna Weissglas-Volkov, Mira Kyttälä, et al.
Genome Research|May 5, 2010
Reprogramming of miRNA networks in cancer and leukemiaStefano Volinia, Marco Galasso, Stefan Costinean, et al.
The Journal of Clinical Investigation|September 4, 2013
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cellsPaolo Neviani, Jason G Harb, Joshua J Oaks, et al.
Pageof 55

Showing results (541-550 of 549) with videos related to

Sort By:
Pageof 55
You have reached the last page of results.This site can display upto 549 results.
Cell Death and Differentiation|October 17, 2018
Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicineMichele Carbone, Ivano Amelio, El Bachir Affar, et al.
The New England Journal of Medicine|April 22, 2005
Familial cancer associated with a polymorphism in ARLTS1George Adrian Calin, Francesco Trapasso, Masayoshi Shimizu, et al.
Gastroenterology|November 9, 2017
MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in CholangiocarcinomaAndrea Lampis, Pietro Carotenuto, Georgios Vlachogiannis, et al.
Cancer Cell|April 17, 2014
MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancerNicola Valeri, Chiara Braconi, Pierluigi Gasparini, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2008
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancerLin Zhang, Stefano Volinia, Tomas Bonome, et al.
Journal of the National Cancer Institute|October 13, 2014
Pluripotent stem cell miRNAs and metastasis in invasive breast cancerStefano Volinia, Gerard Nuovo, Alessandra Drusco, et al.
American Journal of Human Genetics|August 5, 2008
WW-domain-containing oxidoreductase is associated with low plasma HDL-C levelsJenny C Lee, Daphna Weissglas-Volkov, Mira Kyttälä, et al.
Genome Research|May 5, 2010
Reprogramming of miRNA networks in cancer and leukemiaStefano Volinia, Marco Galasso, Stefan Costinean, et al.
The Journal of Clinical Investigation|September 4, 2013
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cellsPaolo Neviani, Jason G Harb, Joshua J Oaks, et al.
Pageof 55